Total Payments
$3,837
2024 Payments
$1,839
Companies
26
Transactions
227
Payment Breakdown by Category
Food & Beverage$3,822 (99.6%)
Education$15.57 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,822 | 226 | 99.6% |
| Education | $15.57 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,077 | 84 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $596.16 | 44 | $0 (2024) |
| QOL Medical, LLC | $278.97 | 13 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $219.62 | 7 | $0 (2024) |
| AIMMUNE THERAPEUTICS, INC. | $217.70 | 15 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $175.62 | 5 | $0 (2023) |
| Braintree Laboratories, Inc. | $161.29 | 8 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $127.26 | 1 | $0 (2024) |
| Lilly USA, LLC | $126.44 | 7 | $0 (2024) |
| Ardelyx, Inc. | $123.27 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,839 | 102 | ABBVIE INC. ($336.77) |
| 2023 | $1,196 | 75 | ABBVIE INC. ($355.15) |
| 2022 | $765.84 | 49 | ABBVIE INC. ($384.70) |
| 2021 | $36.34 | 1 | Edwards Lifesciences Corporation ($36.34) |
All Payment Transactions
227 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.35 | General |
| Category: Gastroenterology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/05/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $103.83 | General |
| Category: Rare Disease | ||||||
| 12/05/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: LIVER DISEASE | ||||||
| 11/22/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Gastroenterology | ||||||
| 11/19/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $8.23 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $3.24 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $11.95 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.08 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $24.81 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $1.08 | General |
| Category: Immunology | ||||||
| 10/25/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $3.80 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: IMMUNOLOGY | ||||||
About Amanda Golaszewski, AG-AC DNP
Amanda Golaszewski, AG-AC DNP is a Acute Care healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1013551175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Golaszewski, AG-AC DNP has received a total of $3,837 in payments from pharmaceutical and medical device companies, with $1,839 received in 2024. These payments were reported across 227 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,822).
Ad
Practice Information
- Specialty Acute Care
- Location Morris Plains, NJ
- Active Since 11/01/2019
- Last Updated 11/01/2019
- Taxonomy Code 363LA2100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013551175
Products in Payments
- RINVOQ (Biological) $577.30
- ZENPEP (Drug) $347.80
- SKYRIZI (Biological) $323.64
- TRULANCE (Drug) $289.72
- XIFAXAN (Drug) $267.00
- OCALIVA (Drug) $219.62
- SUCRAID (Drug) $202.66
- SUTAB (Drug) $161.29
- STELARA (Biological) $135.09
- IBSRELA (Drug) $123.27
- OMVOH (Drug) $107.91
- DUPIXENT (Biological) $106.63
- IQIRVO (Drug) $103.83
- VELSIPITY (Drug) $85.43
- Sucraid (Drug) $76.31
- HUMIRA (Biological) $68.82
- REBYOTA (Biological) $55.12
- ENTYVIO (Biological) $46.67
- VOWST (Biological) $45.52
- MAVYRET (Drug) $44.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.